Breaking News

WuXi STA Adds New Peptide Manufacturing Capacity

With two new 2,000L reactors the total reactor volume of the Solid Phase Peptide Synthesizers at WuXi TIDES has increased to over 10,000L.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO), has added two 2,000 L reactors and a large-scale continuous purification system for peptide manufacturing at its Changzhou campus.   The new additions expand capability and capacity of WuXi TIDES, a CRDMO platform for oligonucleotide, peptide, and related synthetic conjugates (TIDES drugs). TIDES drug development provides all discovery, CMC development, and the manufacturing supply chain under one roof. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters